According to a recent report by iData Research, the overall U.S. market for dental barrier membranes, including resorbable and non-resorbable products, was valued at nearly $120 million in 2014.
Vancouver, BC (PRWEB) May 27, 2015
According to a recently published report by iData Research (http://www.idataresearch.com), the dental barrier membrane market is expected to demonstrate the highest level of growth, primarily stemming from resorbable membrane sales. The majority of dental barrier membrane sales are resorbable. But as non-resorbable membranes continue to serve a specific market, resorbable membrane market will eventually stabilize.
“Resorbable membranes have quickly taken over the barrier membrane market, despite their higher pricepoint,” explains Dr. Kamran Zamanian, CEO of iData. “Though the use of resorbable membranes avoids an additional costly procedure, non-resorbable membranes will continue to have a share of the market due the structural support they provide.”
Resorbable products are generally priced higher than non-resorbable products as they offer additional benefits. Resorbable products therefore pull the average selling price (ASP) of the segment upwards. Pricing within the membrane market is highly dependent on the size of the product. The ASP is calculated by the weight of small, medium or large units of barrier membranes, in addition to the incorporation of pricing differences between resorbable and non-resorbable products.
Other key findings from the iData Research report entitled U.S. Market for Dental Bone Graft Substitutes, Barrier Membranes and Other Biomaterials:
Dental Bone Grafting Procedures
Dental bone grafting procedures often necessitate the use of a barrier membrane in order to direct the growth of the new bone and gingival tissue. The demonstrated growth of dental bone grafting procedures, driven largely by the dental implant market, will lead to a corresponding long-term increase in the number of membranes used. The barrier membrane market is therefore expected to experience parallel growth, in terms of unit sales, with the dental bone graft substitute market.
In 2014, Geistlich was the clear market leader with over a quarter of the U.S. dental barrier membrane market share. Geistlich’s position stems from its bundling of their collagen membrane Bio-Gide® product with their xenograft products. However, due to Geistlich’s focus on regenerative material products, companies that offer a more complete dental portfolio – including dental implants and related products – have been gaining slight market share at the expense of Geistlich.
Other notable competitors in this include ACE Surgical, Zimmer, Osteogenics, BioHorizons, Biomet 3i, DENTSPLY Implants, Salvin, AB Dental, Bicon, Curasan, Dentium, Dyna Dental, Exactech, Impladent, Inion, Keystone Dental, MIS, and Snoasis among others.
For Further Information
More on the dental barrier membrane market in the U.S. can be found in the report series published by iData entitled U.S. Market for Dental Bone Graft Substitutes, Barrier Membranes and Other Biomaterials. This report covers the U.S. markets for dental bone graft substitutes, dental growth factors, and dental barrier membranes.
The iData series on the market for dental bone graft substitutes, barrier membranes and other biomaterials covers the U.S., Brazil, China, Japan, India, U.K., Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, and Switzerland. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
Register online or email us at info(at)idataresearch(dot)net for a U.S. Market for Dental Bone Graft Substitutes, Barrier Membranes and Other Biomaterials report brochure and synopsis.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.
For the original version on PRWeb visit: http://www.prweb.com/releases/2015/05/prweb12746869.htm